Nevertheless, inhibiting NOTCH1 signaling using γ‐Secretase inhibitors (GSI) has demonstrated poor efficacy in the clinical treatment of T-ALL [6]. Here, NOTCH1 is linked to acute lymphoblastic leukemia.